NCT02555085View on ClinicalTrials.gov

Single Ascending Doses of BIIB063 in Healthy Volunteers

PHASE1TerminatedINTERVENTIONAL

Enrollment

29

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

June 1, 2016

Study Completion Date

June 1, 2016

Conditions

Healthy

Interventions

BIOLOGICAL

BIIB063

Single ascending IV dose

OTHER

Placebo

Single dose

Trial Locations (1)

LD2 9LH

Research Site, Leeds

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Biogen

INDUSTRY